HSBC Thinks AbbVie Can Climb to $315. Here's the Bull Case in Plain English.
A recent analyst lays out a concrete bull case, but it is not the only path to higher prices for AbbVie.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.